Expression of CD109 in human cancer

Oncogene

Volumn 23, Issue 20, 2004, Pages 3716-3720

  Hashimoto, Mizuo ^a   Ichihara, Masatoshi ^a   Watanabe, Tsuyoshi ^a   Kawai, Kumi ^a   Koshikawa, Katsumi ^b   Yuasa, Norihiro ^a   Takahashi, Takashi ^b   Yatabe, Yasushi ^b   Murakumo, Yoshiki ^a   Zhang, Jing Min ^a   Nimura, Yuji ^a   Takahashi, Masahide ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

CD109; Esophageal carcinoma; Lung carcinoma; Squamous cell carcinoma

Indexed keywords

CD109 ANTIGEN; PROTEIN RET; PROTEIN TYROSINE KINASE; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CELL STRAIN 3T3; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE MUTATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MOUSE; MULTIPLE ENDOCRINE NEOPLASIA; NEUROBLASTOMA; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TESTIS; UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; BLOTTING, NORTHERN; CARCINOMA, SQUAMOUS CELL; COS CELLS; ESOPHAGEAL NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASMS; ORGAN SPECIFICITY; SEQUENCE ALIGNMENT; TESTIS;

ANIMALIA;

EID: 2442719171     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207418     Document Type: Article

References (13)

1. Haregewoin A, Solomon K, Hom RC, Soman G, Bergelson JM, Bhan AK and Finberg RW. (1994). Cell. Immunol., 156, 357-370.
2. Hofmann K, Bucher P, Falquet L and Bairoch A. (1999). Nucleic Acids Res., 27, 215-219.
3. Lin M, Sutherland DR, Horsfall W, Totty N, Yeo E, Nayar R, Wu X-F and Schuh AC. (2002). Blood, 99, 1683-1691.
4. Murray LJ, Bruno E, Uchida N, Hoffman R, Nayar R, Yeo EL, Schuh AC and Sutherland DR. (1999). Exp. Hematol., 27, 1282-1294.
5. Rappold I, Ziegler BL, Kohler I, Marchetto S, Rosnet O, Birnbaum D, Simmons PJ, Zannettino AC, Hill B, Neu S, Knapp W, Alitalo R, Alitalo K, Ullrich A, Kanz L and Buhring HJ. (1997). Blood, 90, 111-125.
6. Smith JW, Hayward CP, Horsewood P, Warkentin TE, Denomme GA and Kelton JG. (1995). Blood, 86, 2807-2814.
7. Solomon KR, Mallory MA and Finberg RW. (1998). Biochem. J., 334, 325-333.
8. Sutherland DR and Yeo E. (1995). CDw109 Cluster Report: Leukocyte Typing V, Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF and Todd RF (eds). Oxford University Press: Oxford, pp. 1767-1769.
9. Sutherland DR and Yeo E. (1998). CD109 Workshop Panel Report: Leukocyte Typing VI, Kishimoto T, Kikutani H, von dem Borne AEGKr., Goyert SM, Mason DY, Miyasaka M, Moretta L, Okumura K, Shaw S, Springer TA, Sugamura K, Zola H (eds). Garland Publishing: London, pp. 714-716.
10. Sutherland DR, Yeo E, Ryan A, Mills GB, Bailey D and Baker MA. (1991). Blood, 77, 84-93.
11. Takahashi M. (2001). Cytokine Growth Factor Rev., 12, 361-373.
12. Watanabe T, Ichihara M, Hashimoto M, Shimono K, Shimoyama Y, Nagasaka T, Murakumo Y, Murakami H, Sugiura H, Iwata H, Ishiguro N and Takahashi M. (2002). Am. J. Pathol., 161, 249-256.
13. Yeo EL and Sutherland DR. (1992). Blood, 80, 56.